Secondary Logo

Postoperative pneumonia

Can this important complication be predicted and anticipated?

Walder, Bernhard; Story, David A.

European Journal of Anaesthesiology (EJA): February 2019 - Volume 36 - Issue 2 - p 87–89
doi: 10.1097/EJA.0000000000000922
Invited commentaries

From the Peri-interventional Care Unit, Division of Anaesthesiology, Geneva University Hospitals, Geneva, Switzerland (BW) and Centre for Integrated Critical Care, University of Melbourne, Melbourne, Victoria, Australia (DAS)

Correspondence to Prof Bernhard Walder, Peri-interventional Care Unit, Division of Anaesthesiology, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, CH-1211 Geneva 14, Switzerland E-mail:

This Invited Commentary accompanies the following original article:

Russotto V, Sabate S, Canet J, for the PERISCOPE group of the European Society of Anaesthesiology (ESA) Clinical Trial Network. Development of a prediction model for postoperative pneumonia. A multicentre prospective observational study. Eur J Anaesthesiol 2019; 36:93–104.

Postoperative pneumonia is a major postoperative adverse event and one of the frequent hospital-acquired infections.1 Postoperative pneumonia is associated with short-term mortality exceeding 10%, long-term decreased survival along with considerable clinical and economic costs. Prevention, early diagnosis and rescue of patients with postoperative pneumonia are important measures needing the support of all healthcare providers across the peri-operative period.

Diagnosing pneumonia can be difficult because pneumonia is an infection of the lungs from an array of pathogens with varying clinical, biological marker and imaging manifestations. This is particularly so for postoperative pneumonia with both under-diagnosis and over-diagnosis depending on diagnostic criteria. The Standardized Endpoints in Perioperative Medicine group recommended the US Centers for Disease Control and Prevention (CDC) definition for pneumonia (Table 1), at least for research purposes.2 This does not, however, make other diagnostic criteria incorrect. Further, the list of alternative diagnoses to acute pneumonia is long and includes: pulmonary oedema, aspiration pneumonitis, pulmonary embolism, exacerbation of chronic obstructive pulmonary disease (COPD); and atelectasis. Therefore, apart from the difficulty of accurately diagnosing pneumonia, these overlapping diagnoses explain, in part, different pneumonia rates in different studies and disagreement between experts.

Table 1

Table 1

In the accompanying prediction study entitled ‘Development of a prediction model for postoperative pneumonia’,3 Russotto et al. used a pragmatic pneumonia definition, the need for treatment with antibiotics for a respiratory infection and at least one of the following criteria: new or changed sputum; new or changed lung opacities on a clinically indicated chest radiograph; temperature more than 38.3 °C; and leucocyte count more than 12 × 109 l−1. Although this differs from the stricter CDC definition there is likely to be considerable overlap. Further, Russotto et al. found a pneumonia event rate of 2.4% that is similar to earlier investigations with mixed surgical populations: 1.5 and 1.8%.4,5 However, Russotto et al. found pneumonia diagnosed at median time of 1 day after surgery while other studies first recorded postoperative pneumonia later.6 These differences may reflect different pneumonia definitions, be related to other inclusion criteria (elective and nonelective patients), different approaches to data collection, different case mixes with more patients with pre-operative pneumonia identified immediately postoperatively or more patients with intra-operative aspiration.

Several patient-related risk factors for postoperative pneumonia were previously identified: older age; poor nutrition status and pre-operative weight loss; pre-existing dysphagia and swallowing difficulties from neurocognitive or neuromuscular disease; pre-existing comorbidities most often measured with the ASA physical status; immunosuppression including diabetes mellitus or chronic alcohol abuse; pulmonary dysfunction with low pre-existing oxygen saturation related to COPD; pre-existing pneumonia; respiratory muscle wasting and/or smoking history. Frailty may add or replace several of these factors, but, like pneumonia itself, there are currently no universally accepted frailty diagnostic criteria.7

Other previous associations with postoperative pneumonia include general anaesthesia without epidural, neuromuscular blocking agents, hyperoxia, naso-gastric tubes, plane positioning with increased aspiration risk of gastric content, fluid administration, acid-suppressive medication and sedation.

Russotto et al. identified five variables independently associated with postoperative pneumonia. Three known pre-operative predictors: functional status, partially/totally dependent [odds ratio (OR) 2.3], lower pre-operative SpO2 values breathing room air (OR 1.20) and upper abdominal open surgery (OR 4.0). They also found two intra-operative risk factors: colloid fluid therapy (OR 3.0); and blood transfusion (OR 2.2). Association between postoperative pneumonia, operative site, functional status and transfusion are also consistent with previous findings.8–10

Russotto et al. propose two modifiable predictors of pneumonia: blood transfusion and colloids. However, we cannot currently assume that modifying these factors will improve outcomes. Transfusion and colloids may be risk markers rather than causes of pneumonia.

Possible mechanisms for an association between transfusion and pneumonia include the blood loss (i.e. shock) or the transfusion.5,11 Transfusions may be associated with pneumonia potentially via transfusion-related immune modulation, or transfusion-associated cardiac overload or transfusion-associated acute lung injury.12 Therefore, on the balance of probabilities, measures to decreases transfusions could be considered, including patient-specific transfusion triggers, anaemia treatment before surgery, adapted use of peri-operative anticoagulants and antiplatelet drugs, minimally invasive surgery, and use of tranexamic acid. This is particularly so for patients undergoing elective surgery where there is frequent unwanted practice variation in transfusion medicine. Further, transfusion is associated with significant cost to hospitals.

The finding that intra-operative colloids are associated with postoperative pneumonia is in line with an observational study on postoperative pulmonary complications after noncardiothoracic surgery.5 The biological basis for this finding is not clear but may be related to fluid overload with secondary infected atelectasis; or that colloid requirements are a marker of shock severity. However, many regulatory authorities, including those in Europe, the United States and Australia have recommended restricted use of starch colloids, particularly in sicker patients and those with sepsis. Therefore, in many countries, use of this potentially modifiable risk factor is probably already realised. However, the role of albumin as potential risk or protective factor for pneumonia needs to be clarified because in severe sepsis (often secondary to pneumonia) time to haemodynamic stabilisation was shorter with albumin.13

The data from Russotto et al. were collected in 2011; we cannot exclude that changes in surgical and anaesthesia techniques in recent years alter the proposed prediction model. Before widespread implementation of the proposed prediction model in clinical practice an external validation with more recent data and more recent surgical techniques is warranted.

Early detection and adequate treatment of major postoperative adverse events such as pneumonia, are the primary goal of rescue and a central part of clinically effective and cost effective peri-operative medicine. Although diagnosis of pneumonia is based on clinical, microbiological and radiological criteria, in the postoperative period some classical criteria for pneumonia such as fever, leukocytosis and worsening gas exchange are often present without pneumonia. In most patients with suspected pneumonia empiric antibiotics are started before all CDC criteria are available because delay of appropriate antibiotics is a risk factor for mortality in hospital acquired pneumonia. An unresolved issue is the addition of prednisone in postoperative pneumonia but may be considered if the pneumonia is early after surgery and a community-acquired pneumonia is probable.14

In summary, what are our suggestions for practice and implementation research? The first is to adjust our clinical risk thinking in communications with clinicians, patients and families; including asking the value of the planned surgery. The second is to identify possible preventive strategies for higher risk patients who may benefit. For elective patients a pre-operative ambulatory rehabilitation (prehabilitation) could be started with interventions such as anaemia treatment, protein-rich nutrition, smoking cessation programme and general physical training. Evidence for this approach is a recent randomised controlled trial that demonstrated decreased postoperative pneumonia with targeted pre-operative teaching from physiotherapists.15 A further option would be to reduce the severity of the risk factors. However, without adequate clinical trial evidence we cannot estimate the effect of reversing or avoiding risk factors on the outcome postoperative pneumonia. For example, there is no definitive evidence that functional dependence can be reduced but several studies are underway in pre-operative prehabilitation for older frail patients that may answer that question. Third, consider avoiding intra-operative colloids and transfusions. Fourth, adapt postoperative pathways to enhance early detection of pneumonia and adequate treatment (rescue) including planned postoperative intermediate care or high-dependency units.

Russotto et al. may have helped us better predict who is more likely to get postoperative pneumonia. If externally validated, controlled implementation research programs with highly motivated healthcare providers will be warranted with the intention to control and to reduce postoperative pneumonia rate, a major complication.

Back to Top | Article Outline

Acknowledgements relating to this article

Assistance with the Invited Commentary: none.

Financial support and sponsorship: none.

Conflicts of interest: none.

Comment from the Editor: this Invited Commentary was checked and accepted by the editors but was not sent for external peer review. BW is a Deputy Editor-in-Chief of the European Journal of Anaesthesiology.

Back to Top | Article Outline


1. Klompas M. Hospital-acquired pneumonia in nonventilated patients: the next frontier. Infect Control Hosp Epidemiol 2016; 37:825–826.
2. Abbott TEF, Fowler AJ, Pelosi P, et al. A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications. Br J Anaesth 2018; 120:1066–1079.
3. Russotto V, Sabaté S, Canet J. for the PERISCOPE group of the European Society of Anaesthesiology (ESA) Clinical Trial Network. Development of a prediction model for postoperative pneumonia: a multicentre prospective observational study. Eur J Anaesthesiol 2019; 36:93–104.
4. Arozullah AM, Khuri SF, Henderson WG, et al. Participants in the National Veterans Affairs Surgical Quality Improvement Program. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 2001; 135:847–857.
5. Fernandez-Bustamante A, Frendl G, Sprung J, et al. Postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic surgery: a multicenter study by the perioperative research network investigators. JAMA Surg 2017; 152:157–166.
6. Gundel O, Gundersen SK, Dahl RM, et al. Timing of surgical site infection and pulmonary complications after laparotomy. Int J Surg 2018; 52:56–60.
7. Hubbard RE, Story DA. Patient frailty: the elephant in the operating room. Anaesthesia 2014; 69 (Suppl 1):26–34.
8. Kim SW, Han HS, Jung HW, et al. Multidimensional frailty score for the prediction of postoperative mortality risk. JAMA Surg 2014; 149:633–640.
9. Nan DN, Fernandez-Ayala M, Farinas-Alvarez C, et al. Nosocomial infection after lung surgery: incidence and risk factors. Chest 2005; 128:2647–2652.
10. Rohde JM, Dimcheff DE, Blumberg N, et al. Healthcare-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014; 311:1317–1326.
11. Glance LG, Dick AW, Mukamel DB, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114:283–292.
12. Roubinian NH, Looney MR, Keating S, et al. Differentiating pulmonary transfusion reactions using recipient and transfusion factors. Transfusion 2017; 57:1684–1690.
13. Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014; 370:1412–1421.
14. Blum CA, Nigro N, Briel M, et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2015; 385:1511–1518.
15. Boden I, Skinner EH, Browning L, et al. Preoperative physiotherapy for the prevention of respiratory complications after upper abdominal surgery: pragmatic, double blinded, multicentre randomised controlled trial. BMJ 2018; 360:j5916.
© 2019 European Society of Anaesthesiology